0001602462-16-000002.txt : 20160830 0001602462-16-000002.hdr.sgml : 20160830 20160830131042 ACCESSION NUMBER: 0001602462-16-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160830 DATE AS OF CHANGE: 20160830 EFFECTIVENESS DATE: 20160830 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KinDex Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001602462 IRS NUMBER: 270767031 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-269780 FILM NUMBER: 161860080 BUSINESS ADDRESS: STREET 1: 800 FIFTH AVENUE STREET 2: STE. 4100 CITY: SEATTLE STATE: WA ZIP: 98104 BUSINESS PHONE: (206) 447-1455 MAIL ADDRESS: STREET 1: 800 FIFTH AVENUE STREET 2: STE. 4100 CITY: SEATTLE STATE: WA ZIP: 98104 D 1 primary_doc.xml X0707 D LIVE 0001602462 KinDex Pharmaceuticals, Inc. 800 FIFTH AVENUE STE. 4100 SEATTLE WA WASHINGTON 98104 (206) 922-2912 DELAWARE KinDex Therapeutics, LLC None Corporation true Jeffrey S Bland 800 Fifth Avenue Suite 4100 Seattle WA WASHINGTON 98104 Executive Officer Director Roger Colman 800 Fifth Avenue Suite 4100 Seattle WA WASHINGTON 98104 Director Jeffrey J Katke 800 Fifth Avenue Suite 4100 Seattle WA WASHINGTON 98104 Director Paul Schimmel 800 Fifth Avenue Suite 4100 Seattle WA WASHINGTON 98104 Director Lincoln Bouillon 800 Fifth Avenue Suite 4100 Seattle WA WASHINGTON 98104 Executive Officer Michael Higgins 800 Fifth Avenue Suite 4100 Seattle WA WASHINGTON 98104 Director Neile A Grayson 800 Fifth Avenue Suite 4100 Seattle WA WASHINGTON 98104 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2016-08-16 false true true true false 0 600001 327274 272727 false 4 0 0 0 false KinDex Pharmaceuticals, Inc. Lincoln Bouillon Lincoln Bouillon Chief Financial Officer 2016-08-30